Concepedia

Author

Salim Chahin

Washington University in St. LouisORCID

Also Known As

S. Chahin, Salim Chahin

54

Publications

1.3K

Citations

19

H-Index

38

Concepts

All Affiliations

Washington University in St. LouisUniversity of PennsylvaniaJohns Hopkins UniversityUniversity of California, San FranciscoIcahn School of Medicine at Mount Sinai
SC

About

Salim Chahin is an author at Washington University in St. Louis specializing in medicine, multiple sclerosis, and neurology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

202

2

Public Health

1

1

41

3

Social Sciences

1

1

28

4

Emergency Medicine

1

1

14

5

Health Informatics

1

1

14

Salim Chahin

×

23

Publications

1.2K

Citations

18

H-Index

YearCitations

Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2

Parakkal Deepak, Wooseob Kim, Michael Paley,

Annals of Internal Medicine

2021

313

Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2

Parakkal Deepak, Wooseob Kim, Michael Paley,

2021

139

Acute disseminated encephalomyelitis in 228 patients

Diederik L H Koelman, Salim Chahin, Soe Mar,

Neurology

2016

121

Challenges in multiple sclerosis diagnosis: Misunderstanding and misapplication of the McDonald criteria

Andrew Solomon, Roman Pettigrew, Robert T. Naismith,

Multiple Sclerosis Journal

2020

66

Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count

Erin E. Longbrake, Claudia Cantoni, Salim Chahin,

Multiple Sclerosis Journal

2017

56

Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica

John R. Ciotti, Noah S Eby, Gregory F. Wu,

Multiple Sclerosis and Related Disorders

2020

52

Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial

Daniel Ontaneda, Pascal Sati, Praneeta Raza,

NeuroImage Clinical

2021

52

A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy

Salim Chahin, Joseph R. Berger

Journal of NeuroVirology

2014

41

“Brain age” predicts disability accumulation in multiple sclerosis

Matthew R. Brier, LI Zhuo-cheng, Maria Ly,

Annals of Clinical and Translational Neurology

2023

40

Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

Jacqueline Palace, Dean M. Wingerchuk, Kazuo Fujihara,

Multiple Sclerosis and Related Disorders

2020

37

Page 1